Among the investigated gene loci, the genes involved in the dopamine–prolactin pathway, including the neuropeptide Y gene (NYP) [173] and prolactin gene (PRL) [174], may also attract attention to their contribution to the comorbidity of schizophrenia and metabolic syndrome [102,148,156]. This evidence concerns the gene PRL and metabolic syndrome.